Alex advises a broad mix of multinational corporates, financial institutions and state-owned enterprises on complex and high value cross-border M&A deals, joint ventures and other global transactions.
He works across a wide range of sectors, including the energy and natural resources, pharmaceuticals and healthcare, consumer goods, and aerospace and defence sectors.
Alex is a member of Freshfields’ Africa group and, over the past decade, has worked on deals involving 37 countries across the continent. Recently, Alex was seconded to the Nairobi office of a leading pan-African law firm, where he worked on a number of market-leading private and public acquisitions throughout East Africa.
AB InBev on its $120bn merger with SABMiller, the largest ever UK public takeover and the largest ever M&A transaction in South Africa.
AB InBev on its disposal of SABMiller’s majority stake in Coca-Cola Beverages Africa for $3.15bn.
Occidental Petroleum on the international aspects of its US$57bn acquisition of Anadarko, including on the contingent $8.8bn sale of Anadarko's African assets to Total.
its acquisition of Maersk Oil for $7.45bn, settled in Total shares and assumed debt (World Oil & Gas Awards Deal of the Year); and
its acquisition of Chevron Denmark.
Neptune Energy on its US$3.9bn acquisition of ENGIE E&P International and on its proposed acquisition of Edison’s UK and Norwegian North Sea assets from Energean
the spin-off of its Alcon division;
its proposed acquisition of GSK's cephalosporin business; and
its portfolio transformation, involving three inter-conditional transactions with a total value of more than $30 billion: the acquisition of oncology products from GSK; the formation of a consumer healthcare joint venture with GSK; and the sale to GSK of the Novartis vaccines division (excluding flu).
Aon on its proposed $30bn merger with Willis Towers Watson.
JAB on its acquisition of Pret A Manger.
Red and White Securities Limited on the sale of its shares in Arsenal Holdings PLC to KSE, UK, Inc., an entity wholly owned by Stanley Kroenke.
ArcLight Capital Partners on the $900m acquisition of the SIRGES gas pipeline (67 per cent interest), the St Fergus Gas Terminal and the FUKA natural gas pipeline from Total.
AstraZeneca on its defence of Pfizer’s approaches.
Rolls-Royce on the sale of its oil and gas/energy gas turbine business to Siemens for £1bn.
Rolls-Royce on a number of other transactions in the aerospace and defence sectors.
A multinational consumer goods company on the sale of a porfolio of consumer products.
A leading media firm on its acquisition of an interest in a venture capital backed telecommunications start-up company.
On the settlement between the Karachaganak consortium (BG, Eni, Chevron and LUKoil) and the Republic of Kazakhstan, including the $3bn transfer of 10 per cent of the consortium’s upstream interests to KazMunayGas.